| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/12/2004 | EP1416930A1 Pramipexole for the treatment of adhd |
| 05/12/2004 | EP1416929A2 Cancer treatment with gö6976 and its related compounds |
| 05/12/2004 | EP1416926A2 Zinc containing compositions for anti-viral use |
| 05/12/2004 | EP1416924A1 Adjuvant chemotherapy for anaplastic gliomas |
| 05/12/2004 | EP1416922A1 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 05/12/2004 | EP1416919A1 Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| 05/12/2004 | EP1416915A1 Enhanced pharmacokinetic profile of hydrophobic substances |
| 05/12/2004 | EP1416885A2 Methods and devices for delivery of therapeutic capable agents with variable release profile |
| 05/12/2004 | EP1416884A2 Delivery of therapeutic capable agents |
| 05/12/2004 | EP1200432B1 Amido spiropiperidines promote the release of growth hormone |
| 05/12/2004 | EP1171124A4 Anthelmintic compositions |
| 05/12/2004 | EP1131067B1 Composition and use of rar antagonists for promoting chondrogenesis |
| 05/12/2004 | EP1067966B1 Ophthalmic composition comprising a beta-blocker |
| 05/12/2004 | EP1058559B1 Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor |
| 05/12/2004 | EP0969720A4 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/12/2004 | EP0862444B1 Treatment of dilated cardiomyopathy by removal of autoantibodies |
| 05/12/2004 | EP0781092B1 Nucleic acid encoding adenovirus e1a polypeptide for sensitizing tumor cells to chemotherapy or irradiation |
| 05/12/2004 | CN1496404A Materials and methods relating to protein aggregation in neurodegenerative disease |
| 05/12/2004 | CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 05/12/2004 | CN1496349A (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane, compositions and uses thereof |
| 05/12/2004 | CN1496265A Medicine for fighting against sexual dysfunction |
| 05/12/2004 | CN1496262A Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 05/12/2004 | CN1496259A New use |
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/12/2004 | CN1496256A Combination of EPOTHILONE analogs and chemotherapeutic agents for treatment of proliferative diseases |
| 05/12/2004 | CN1496254A Treatment of male sexual dysfunction |
| 05/12/2004 | CN1495253A Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 05/12/2004 | CN1494905A Medicine composition containing anti-tumor medicine and hydroximic acid derivative and having anti-tumor enhanced acitity and/or reducing side effect |
| 05/12/2004 | CN1494903A Preventing or curing agent for eye fatigue and pseudomyopia |
| 05/12/2004 | CN1149281C Kinase activating dependent cyclin protein kinases, and their uses |
| 05/12/2004 | CN1149219C New compounds for treatment of cancer |
| 05/12/2004 | CN1149215C Phenyl Yanthine derivatives |
| 05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
| 05/12/2004 | CN1149087C Endothelin antagonist and beta receptor blocking agent as comblined preparation |
| 05/12/2004 | CN1149080C Prilocaine and hydrofluorocarbon aerosol preparations |
| 05/12/2004 | CN1149077C Rapidly disintegrable solid preparation |
| 05/12/2004 | CN1149072C New pharmaceutical composition with anaesthetic effect |
| 05/11/2004 | US6734192 Administering quercetin or derivatives thereof, with the channel blocker and quinoline for treatment of hiv infection |
| 05/11/2004 | US6734188 Composition for treatment of constipation and irritable bowel syndrome |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734178 Contacting host with a cephalotaxine and an antiproliferative agent such as an alkylating agent, an intercalating agent, a metal coordination complex, a nucleoside, a nucleic acid enyme or protein inhibitor to modulate cell proliferation |
| 05/11/2004 | US6734175 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6734003 Phosphodiesterase 10 |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733982 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 05/11/2004 | US6733978 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/11/2004 | US6733792 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 05/11/2004 | US6733769 Edible viscosity lowering polysaccharide; a maltodextrin-glucomannan complex |
| 05/11/2004 | US6733751 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 05/11/2004 | US6733743 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 05/11/2004 | CA2312898C Long acting injectable formulations containing hydrogenated castor oil |
| 05/11/2004 | CA2302033C Methods and compositions for enhanced wound healing |
| 05/11/2004 | CA2156481C 5-ht2 receptor antagonist compositions useful in treating venous conditions |
| 05/11/2004 | CA2104594C Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 05/06/2004 | WO2004037865A1 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 05/06/2004 | WO2004037843A2 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments |
| 05/06/2004 | WO2004037311A2 Device and methods for sequential, regional delivery of multiple cytotoxic agents |
| 05/06/2004 | WO2004037291A1 Pharmaceutical product for endonasal administration for treating central nervous system diseases and disorders |
| 05/06/2004 | WO2004037290A1 Sustained release composition for oral administration of drugs |
| 05/06/2004 | WO2004037288A1 Agent eleveting dendritic cell precursor level in blood |
| 05/06/2004 | WO2004037262A2 Immediate release topical pharmaceutical formulation for enhancement of female sexual desire and responsiveness |
| 05/06/2004 | WO2004037261A1 Use of n-‘5-‘4-(4-methylpiperaziomethyl)-benzoylamido!-2-methylphenyl!-4-(3-pyridyl)2-pyridine-amine for the treatment of pulmonary hypertension |
| 05/06/2004 | WO2004037258A1 A combination comprising combretastatin and anticancer agents |
| 05/06/2004 | WO2004037254A1 Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 05/06/2004 | WO2004037235A2 Method and composition for preventing and treating solid tumors |
| 05/06/2004 | WO2004037233A2 Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases |
| 05/06/2004 | WO2004037227A1 Salmeterol superfine formulation |
| 05/06/2004 | WO2004037207A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain |
| 05/06/2004 | WO2004037199A2 Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 05/06/2004 | WO2004037197A2 Antifungal formulations |
| 05/06/2004 | WO2004037196A2 Cytomodulating peptides and methods for treating neurological disorders |
| 05/06/2004 | WO2004037186A2 Prophylactic treatment methods |
| 05/06/2004 | WO2004037184A2 Methods for the treatment of skin disorders |
| 05/06/2004 | WO2004037173A2 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | WO2004021992A9 Delivery of therapeutics to the brain and spinal cord |
| 05/06/2004 | WO2004013629A3 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 05/06/2004 | WO2004004750A3 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 05/06/2004 | WO2004004644A3 Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms |
| 05/06/2004 | WO2004003562A3 Oncolytic viruses as phenotyping agents for neoplasms |
| 05/06/2004 | WO2004001068A3 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 05/06/2004 | WO2004001002A3 Novel anticholesterol compositions and method for using same |
| 05/06/2004 | WO2004000042A3 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 05/06/2004 | WO2003105838A3 MODULATION OF ACTIVATION OF GLUCOCORTICOID RECEPTORS beta-BREAKDOWN PRODUCTS OF GLUCOCORTICOIDS |
| 05/06/2004 | WO2003099318A3 Pancreas-specific proteins |
| 05/06/2004 | WO2003092580A3 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 05/06/2004 | WO2003072801A3 Compositions and method for regulation of calcium-dependent signalling in brain |
| 05/06/2004 | WO2003051304A3 Bioadhesive drug delivery system with enhanced gastric retention |
| 05/06/2004 | WO2003050502A9 Prospective identification and characterization of breast cancer stem cells |
| 05/06/2004 | WO2003046008A9 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| 05/06/2004 | WO2003037889A8 Compounds and method for the treatment of overactive bladder |
| 05/06/2004 | WO2003025019A9 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 05/06/2004 | WO2003020219B1 Aerosolized decongestants for the treatment of sinusitis |
| 05/06/2004 | WO2003011903A3 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 05/06/2004 | WO2002096348A3 Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 05/06/2004 | WO2002092788A9 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 05/06/2004 | WO2002087510A3 Subcellular targeting of therapeutic proteins |
| 05/06/2004 | WO2002083240A9 Aromatase inhibition to enhance assisted reproduction |
| 05/06/2004 | WO2002072098A8 Method of treatment |
| 05/06/2004 | WO2002038108A3 Methods of treating disorders related to apoe |